Microbix Biosystems Inc. (TSX:MBX)
Canada · Delayed Price · Currency is CAD 0.2850
+0.0050 (1.79%)
Jun 10, 2026, 10:15 AM EST
Microbix Biosystems Market Cap
Microbix Biosystems has a market cap or net worth of CAD 38.57 million as of June 10, 2026. Its market cap has decreased by -19.42% in one year.
Market Cap
38.57M
Enterprise Value
37.24M
Revenue
14.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.29
Market Cap Chart
Since October 1, 1992, Microbix Biosystems's market cap has increased from 13.38M to 38.57M, an increase of 188.26%. That is a compound annual growth rate of 3.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 38.57M | 20.67% |
| Dec 31, 2025 | 31.97M | -41.99% |
| Dec 31, 2024 | 55.10M | 3.47% |
| Dec 29, 2023 | 53.25M | -6.55% |
| Dec 30, 2022 | 56.99M | -47.62% |
| Dec 31, 2021 | 108.80M | 135.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sernova Biotherapeutics | 56.55M |
| NurExone Biologic | 54.31M |
| MedMira | 42.10M |
| Medicenna Therapeutics | 38.77M |
| Defence Therapeutics | 37.89M |
| BriaCell Therapeutics | 36.80M |
| Resverlogix | 34.38M |
| Quantum BioPharma | 34.23M |